Evaluate the initial dose-effect and time-effect relationship of the injection product NC527-X
1. Voluntarily sign a written informed consent form;
2. Male and female individuals aged 18 years or above;
3. Patients with solid tumors that have been diagnosed by imaging tests or confirmed by pathology and who are scheduled for surgical removal;
4. The ECOG score ranges from 0 to 1;
1. Has a history of allergic reactions to similar products, contrast agents, or fluorescent lamps, or is known to be allergic to the study drug or any other components.
2. 28 days prior to the first administration, the subject had received a similar drug (such as indocyanine green for injection);
3. Within one month prior to the first administration, participants were enrolled in another clinical study (including observational or non-interventional clinical studies);
4. Within 28 days prior to the first administration, had received a live attenuated vaccine;